Analysis of clinical prognostic factors for survival and time to progression in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapy.
about
Does ethnicity affect survival following colorectal cancer? A prospective, cohort study using Iranian cancer registry.New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer.Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy.Multivariate explanatory model for sporadic carcinoma of the colon in Dukes' stages I and IIa.Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival.Classifying the stage IV colorectal cancer: prognostic impact of radical resection for colorectal liver metastases and proposal for a new staging system.Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.Prognosis of colorectal cancer with liver metastasis: value of a prognostic index.Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer.Inference for cumulative incidence quantiles via parametric and nonparametric approaches.The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study.
P2860
Q34993015-0077EB6E-A521-4780-BD02-2FBADF42EA59Q36614777-94493440-0A39-4A87-B4F1-6CAED59D3FAAQ36942747-95102C74-4E20-4FB4-BA88-5FEA0096CC6CQ37093154-7AC5527A-9A32-4694-A584-659A933FFC52Q37995052-A51D0EB4-F49A-45E6-ABA5-82B17F78B7EFQ38093478-A4F0CD17-5C4A-4B7A-8294-39D6247D688CQ40363878-70D47E49-C9DF-468D-887F-5E8FB51E8942Q44611267-9DDB3383-15B6-419A-A554-28F831572D70Q44977172-AFF856F3-2EC5-45CA-B86F-9EEFDE9851B4Q45378695-F84F8A56-E89C-494E-8249-C6AE66498A5CQ50566746-46B265E8-4C24-4EF0-8609-B927A8C4BC6A
P2860
Analysis of clinical prognostic factors for survival and time to progression in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Analysis of clinical prognosti ...... uorouracil-based chemotherapy.
@ast
Analysis of clinical prognosti ...... uorouracil-based chemotherapy.
@en
type
label
Analysis of clinical prognosti ...... uorouracil-based chemotherapy.
@ast
Analysis of clinical prognosti ...... uorouracil-based chemotherapy.
@en
prefLabel
Analysis of clinical prognosti ...... uorouracil-based chemotherapy.
@ast
Analysis of clinical prognosti ...... uorouracil-based chemotherapy.
@en
P2093
P356
P1476
Analysis of clinical prognosti ...... uorouracil-based chemotherapy.
@en
P2093
Ana L Yuste
Angel Segura
Jorge Aparicio
José A Pérez-Fidalgo
Pedro López-Tendero
Regina Gironés
Roberto Díaz
Verónica Calderero
P304
P356
10.3816/CCC.2003.N.004
P407
P577
2003-02-01T00:00:00Z